SPRUCE BIOSCIENCES INC

Spruce Biosciences is trading -1.85 percent lower with a volume of USD 3.3 mn on Monday 26th of October

Spruce Biosciences (SPRB) shares dip 1.85%, now $44.99, amid a 7.9% monthly decline. Learn its market cap, 52‑week range, and biotech focus on endocrine disorders.

SPRUCE BIOSCIENCES INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

26/10/2026, 15:13

2 minutes to read

Spruce Biosciences Stock Rises 1.89% to $41.23 Amid Mid‑Market Biotech Outlook

Spruce Biosciences rises 1.9% to $41.23, trading below its 200‑day SMA, amid a 24‑week decline and biotech sector volatility.

SPRUCE BIOSCIENCES INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 08:36

2 minutes to read